Technology Impact Award

These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.

Funding: $100,000 per year 

Duration: 2 years  

Research Authority due date: 8.11.21

LOI (required) due date: 15.11.21

Full proposal due date: 15.3.22